» Articles » PMID: 25585323

Race, Ethnicity, and the Diagnosis of Breast Cancer

Overview
Journal JAMA
Specialty General Medicine
Date 2015 Jan 14
PMID 25585323
Citations 9
Authors
Affiliations
Soon will be listed here.
Citing Articles

Racial disparities in health insurance, triple-negative breast cancer diagnosis, tumor stage, treatment and survival in a large nationwide SEER cohort in the United States.

Du X Mol Clin Oncol. 2022; 16(4):95.

PMID: 35368847 PMC: 8943535. DOI: 10.3892/mco.2022.2528.


Association of Adjuvant Hormone Therapy Timing With Overall Survival Among Patients With Hormone Receptor-Positive Human Epidermal Growth Factor Receptor-2-Negative Early Breast Cancer Without Chemotherapy.

Fu F, Yu L, Zeng B, Chen M, Guo W, Chen L JAMA Netw Open. 2022; 5(2):e2145934.

PMID: 35166783 PMC: 8848199. DOI: 10.1001/jamanetworkopen.2021.45934.


Axillary Recurrence in Breast Cancer Patients After Negative Sentinel Lymph Node Biopsy: Retrospective Cohort Study From Riyadh, Saudi Arabia.

Alsunitan R, Al-Saif A, Alyousef B, Alghamdi S, Bugshan S Cureus. 2021; 13(12):e20132.

PMID: 34900499 PMC: 8649977. DOI: 10.7759/cureus.20132.


Disparities in Breast Cancer Survivors in Rural West Texas.

Khan H, Rasmussen D, Gabbidon K, Palle K, Rafiq A, Faysel M Cancer Control. 2021; 28:10732748211042125.

PMID: 34473004 PMC: 8419545. DOI: 10.1177/10732748211042125.


Germline ancestry influences the evolutionary disease course in lung adenocarcinomas.

Schenk A, Lopez S, Kschischo M, McGranahan N Evol Appl. 2020; 13(7):1550-1557.

PMID: 32952607 PMC: 7484830. DOI: 10.1111/eva.12964.


References
1.
Gwyn K, Bondy M, Cohen D, Lund M, Liff J, Flagg E . Racial differences in diagnosis, treatment, and clinical delays in a population-based study of patients with newly diagnosed breast carcinoma. Cancer. 2004; 100(8):1595-604. DOI: 10.1002/cncr.20169. View

2.
Grubbs S, Polite B, Carney Jr J, Bowser W, Rogers J, Katurakes N . Eliminating racial disparities in colorectal cancer in the real world: it took a village. J Clin Oncol. 2013; 31(16):1928-30. PMC: 3661932. DOI: 10.1200/JCO.2012.47.8412. View

3.
Griggs J, Sorbero M, Stark A, Heininger S, Dick A . Racial disparity in the dose and dose intensity of breast cancer adjuvant chemotherapy. Breast Cancer Res Treat. 2003; 81(1):21-31. DOI: 10.1023/A:1025481505537. View

4.
Smith K, Wray L, Klein-Cabral M, Schuchter L, Fox K, Glick J . Ethnic disparities in adjuvant chemotherapy for breast cancer are not caused by excess toxicity in black patients. Clin Breast Cancer. 2005; 6(3):260-6. DOI: 10.3816/CBC.2005.n.029. View

5.
Ray M, Polite B . Triple-negative breast cancers: a view from 10,000 feet. Cancer J. 2010; 16(1):17-22. DOI: 10.1097/PPO.0b013e3181d3eef5. View